
Dr. Neeti Srivastava has been a key member of Bezwada Biomedical since 2009, bringing over 15 years of experience in biomedical research and a Ph.D. in Biochemistry. With deep expertise in absorbable polymers, drug delivery systems, biomaterials, and quality management systems, Dr. Srivastava leads research and development, business development, and quality assurance, always focusing on creating innovative, safe, and effective solutions to improve patient care. Dr. Srivastava has extensive knowledge of Bezwada’s absorbable polyurethane technology, including bio-based polyurethanes, and holds patents on the technology, solidifying her position as a leader in polymer science. Her contributions were essential in the creation of TissuBond™, a tissue adhesive that secured NSF SBIR Phase I and II grants. She also worked on absorbable polyurethane formulations for a bone hemostat product that received 510(k) approval from the FDA and was commercialized as MONTAGE® by Abyrx, Inc. Her leadership and dedicated efforts were instrumental in Bezwada Biomedical’s achievement of ISO 9001 and ISO 13485 certifications. Through her guidance in building a robust quality management system, she has ensured the company’s commitment to delivering safe and effective polymers that meet the highest regulatory standards. Dr. Srivastava is also an established voice in the scientific community, having authored multiple scholarly articles and presented her research at esteemed conferences such as the American Chemical Society and the Society for Biomaterials. Her work continues to drive both academic and industrial advancements in biomedical science and drug delivery technologies. Dr. Srivastava will be speaking at the upcoming Biofabrication for Bone event.
When was the first time you encountered 3D printing?
Neeti: I had a basic understanding of 3D printing from reading and attending conferences, but my first real, hands-on experience came when our company received a request to develop custom 3D bioinks. That project was my practical introduction to how 3D printing can be applied in the biomedical field. Designing the bioinks gave me a deeper understanding of the technical challenges and possibilities. I remember feeling excited, realizing this wasn’t just a concept anymore, but something we could actively contribute to.
What inspired you to start your journey?
Neeti: At Bezwada Biomedical, we work with biodegradable polymers, and I saw a chance to use those materials in 3D printing for medical applications. I was inspired by the potential to create more personalized and effective treatments for patients.
Who inspired you the most along this journey ?
Neeti: My biggest inspiration has been my mentor, Dr. Rao Bezwada. His guidance and support have been invaluable throughout my journey. He encouraged me to explore new technologies, such as 3D bio-printing, and always pushed me to innovate and think creatively. Besides him, I’m also inspired by the patients who stand to benefit from these advancements; they remind me every day why this work matters.
What motivates you the most for your work?
Neeti: I am motivated by the impact our work can have, helping people live healthier lives through better medical solutions. The idea that the material we develop could improve someone’s recovery or quality of life keeps me going.
What is/are the biggest obstacle(s) in your line of work? If you have conquered them, what were your solutions?
Neeti: One big challenge is turning a new material into a real product that’s safe, effective, and approved for use. We overcome this by planning early, working closely with different teams, and testing thoroughly.
What do you think is (are) the biggest challenge(s) in 3D Bio-printing? What do you think the potential solution(s) is (are)?
Neeti: One major challenge is making printed tissues that actually work like real tissues/organs inside the body. We need better materials and more innovative designs. Another challenge is regulation; more straightforward rules and standards will help the field grow faster.
If you are granted three wishes by a higher being, what would they be?
Neeti:
- A perfect material that can safely mimic natural tissue.
- Better access to medical innovations for people everywhere.
- Endless creativity for young scientists and engineers.
What advice would you give to a bright, driven college student in the “real world”? What bad advice have you heard that they should ignore?
Neeti: My advice: stay curious, be open to learning, and don’t be afraid to try new things. Ignore advice that says you must stick to one career path; it’s okay to explore and change direction as you grow.
What’s your favorite book you read this year and why?
Neeti: To be honest, I don’t read many books regularly because of my busy schedule. However, I enjoy learning through articles, research papers, and staying updated with the latest in science and technology. I’m always open to recommendations for good books to read when I get the chance!
Related Links:
- Interview – Dr. Rao Bezwada: Absorbable Polymers for 3D Printing
- What Are the Latest Advances in Biomaterials for 3D Bioprinting? – A summary of cutting-edge innovations in next-gen bioinks and biocompatible materials for tissue engineering.
- Interview with Julien Barthes: Silicone 3D Printing – material pioneer, exploring flexible silicone-based 3D printing and biomaterials.
- Interview with Eric Bennett: Frontier Bio
- Interview with Jasper Van Hoorick: BIO INX
- Interview with Prof. Ibrahim Tarik Ozbolat: 3D Bioprinting – Features insights from one of the field’s leading academic researchers on bioprinting and biomaterial innovations.
- The Art and Science of Bioinks – Highlights best practices and challenges in designing effective bioinks for cellular compatibility and manufacturability.
- Challenges & Opportunities in Medical 3D Printing – Explores the technical, regulatory, and material challenges of medical-grade 3D printing
- 3D Bioprinting for Regenerative Medicine: Part 1 – Focuses on the intersection of bioprinting, bioinks, and regenerative material design.


Oct 23, 2025
Comments